Houston, TX, United States of America

Moise Levy


Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 27(Granted Patents)


Company Filing History:

goldMedal1 out of 832,680 
Other
 patents

Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Moise Levy: Pioneer in NFkappa B Activation Research

Introduction: Moise Levy, a distinguished inventor based in Houston, TX, has made significant contributions to the field of medical research with his groundbreaking patent focused on the diagnosis and treatment of medical conditions associated with defective NFκB activation, specifically Incontinentia Pigmenti (IP).

Latest Patents: Moise Levy holds one patent for his innovative methods, compositions, and kits aimed at addressing defects in NFκB related diseases such as IP.

Career Highlights: With a keen focus on NFκB Essential Modulator and its role in inflammatory and apoptotic pathways, Moise Levy has paved the way for advancements in the treatment of neurocutaneous genodermatoses. His dedication to this complex field has led to the development of novel approaches for managing conditions like IP.

Collaborations: Throughout his career, Moise Levy has collaborated with esteemed colleagues in the industry, including Sue J Kenwrick and Hayley Woffendin. Together, they have shared insights, conducted research, and worked towards improving healthcare outcomes for those affected by NFκB related diseases.

Conclusion: Moise Levy's work exemplifies a commitment to innovation and excellence in the realm of medical research. His patent stands as a testament to his dedication to advancing the field and improving the lives of individuals impacted by NFκB related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…